GlassScriptPhysician profile
Rene L Gelber
NPI 1376513390
$625.85
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $173 · 2021: $47.33.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $250.07 | 2019-2021 | |
| Tactile Systems Technology INC | $207.22 | 2019-2020 | |
| Integra Lifesciences Corporation | $45.00 | 2019 | |
| Convatec INC. | $32.69 | 2019-2020 | |
| Melinta Therapeutics, LLC | $31.50 | 2019 | |
| Aroa Biosurgery Incorporated | $23.38 | 2020 | |
| Boston Scientific Corporation | $23.36 | 2021 | |
| Kerecis Limited | $12.63 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Gelber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.